Global Anticoagulants Market Outlook 2025: Revenue & Demand Insights According to a newly published market research report by 24LifeSciences, global anticoagulants market was valued at USD 24,910 million in 2024 and is projected to reach USD 34,970 million by 2031, growing at a compound annual growth rate (CAGR) of 5.1% during the forecast period 2025–2031. Anticoagulants, often referred to as blood thinners, are a vital class of pharmaceutical agents that prevent or treat dangerous blood clots by interrupting the coagulation process. These medications are indispensable for managing life-threatening conditions such as atrial fibrillation (AF), deep vein thrombosis (DVT), pulmonary embolism (PE), and acute coronary syndromes (ACS). Their critical role in stroke prevention and post-surgical care continues to solidify their position as a cornerstone of modern cardiovascular and thrombotic disorder management. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7346/anticoagulants-market

Global Pharmaceuticals Sodium Hydroxide Market to Reach USD 2.72 Billion by 2032 Sodium Hydroxide (NaOH) remains indispensable in producing active pharmaceutical ingredients (APIs), anticoagulants, and analgesics. Its applications extend to biotechnology for buffer solutions and lab-scale research. Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/277849/global-pharmaceuticals-sodium-hydroxide-market-market-2024-146